Annals of Oncology 14:1006-1007, 2003
© 2003 European Society for Medical Oncology
Original Paper |
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer
Ullevaal University Hospital, Oslo, Norway
| The first 10% of the full text of this article appears below. |
| Incidence |
|---|
- The crude incidence of rectal cancer in the European Union is approximately 35% of the total colorectal cancer incidence, i.e. 1525 cases/100 000 per year.
The mortality is 410 cases/100 000 per year with the lower figures valid for females, the higher for males.
| Diagnosis |
|---|
- Diagnosis is based on a clinical rectal examination including rigid proctoscopy with biopsy for histopathological examination. Tumors
. . . [Full Text of this Article]
| Staging and risk assessment |
|---|
| Treatment plan |
|---|
Resectable cases
Primary non-resectable cases and local recurrences
Locally advanced and disseminated disease
| Follow-up |
|---|
| Note |
|---|
| Literature |
|---|
This article has been cited by other articles:
![]() |
H. Ludwig A Foundation for the future Ann. Onc., January 1, 2005; 16(1): 3 - 3. [Full Text] [PDF] |
||||
![]() |
H. Ludwig European Society of Medical Oncology membership survey Ann. Onc., February 1, 2004; 15(2): 181 - 182. [Full Text] [PDF] |
||||
